News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Tasneem Lokhandwala

Articles by Tasneem Lokhandwala

15 Concurrent Use of Abemaciclib and Radiation Therapy (RT) Among Patients With HR+, HER2– Metastatic Breast Cancer (MBC): Real-World Utilization and Safety

15 Concurrent Use of Abemaciclib and Radiation Therapy (RT) Among Patients With HR+, HER2– Metastatic Breast Cancer (MBC): Real-World Utilization and Safety

ByWambui Gathirua-Mwangi,Sangmi Kim,Holly Martin,Tasneem Lokhandwala,Shen Zheng,Eileen Farrelly,Sarah Rybowski

August 13th 2024

Latest Updated Articles

Trending on CancerNetwork

FDA Permits Expanded Daraxonrasib Access in Previously Treated Metastatic PDAC

Precision Medicine and the “Slow Death” of Transplant in Lymphoma

FDA ODAC Votes No to Camizestrant for HR+/HER2– ESR1 Advanced Breast Cancer

135 Elacestrant in Combination With Everolimus or Abemaciclib in Patients With ER+/HER2– Locally Advanced or Metastatic Breast Cancer (mBC): Phase 2 Results From ELEVATE, an Open-Label, Umbrella Study

Shifting Towards Cell Therapy Optimization Across Hematologic Malignancies